Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay

Epidemiology and Infection

Volumn 131, Issue 1, 2003, Pages 703-709

  van den Hof, S ^a   Beaumont, M T A ^a   Berbers, G A M ^a   de Melker, H E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ARTICLE; CHILD; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HERD; HUMAN; IMMUNIZATION; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MUMPS; NETHERLANDS; POPULATION RESEARCH; RELIABILITY; RELIGIOUS GROUP; SEROPREVALENCE; VACCINATION; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUMPS; MUMPS VACCINE; NETHERLANDS; NEUTRALIZATION TESTS; REPRODUCIBILITY OF RESULTS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0043281504     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803008641     Document Type: Article

References (13)

1. Plotkin SA, Wharton M. Mumps vaccine. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines, 3rd edn. Philadelphia: WB Saunders, 1999: 267-292.
2. Baum GB, Litman N. Mumps virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churchill Livingstone, 2000: 1776-1781.
3. Galbraith NS, Young SE, Pusey JJ, Crombie DL, Sparke JP. Mumps surveillance in England and Wales 1962-81. Lancet, 1984; i: 91-94.
4. Inspectorate of Health. Vaccination status in the Netherlands per 1 January 2001. The Hague, The Netherlands, 2002.
5. Hirasing RA, Schaapveld K. Vaccinatie tegen bof succesvol. Ned Tijdschr Geneeskd 1984; 128: 1150-1152.
6. Melker HE de, Conyn-van Spaendonck MAE. Immunosurveillance and the evaluation of national immunisation programmes: a population-based approach. Epidemiol Infect 1998: 121; 637-643.
7. Hof S van den, Berbers GAM, Melker HE de, Conyn-van Spaendonck MAE. Seroepidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in municipalities with low vaccine coverage. Vaccine 1999; 18: 931-940.
8. Harmsen T, Jongerius MC, Zwan CW van der, Plantinga AD. Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps. J Clin Microbiol 1992; 30: 2139-2144.
9. Christenson B, Böttiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals 1990; 18: 207-211.
10. Wagenvoort JHT, Harmsen M, Khader Boutahar-Trouw BJ, Kraaijeveld CA, Winkler KC. Epidemiology of mumps in the Netherlands. J Hyg 1980; 85: 313-326.
11. Usonis V, Bakasenas V, Denis M. Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385. Infection 2001; 29: 159-161.
12. Andrews N, Pebody RG, Berbers G. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000; 125: 127-141.
13. Nardone A, Pebody RG, Hof S van den, et al. Sero-epidemiology of mumps in Western Europe. Epidemiol Infect 2003; 131: 691-701.